Braxia Scientific Corp. Stock Analysis BRAX.CN
Braxia Scientific Corp. is a medical research company, which engages in owning and operating multidisciplinary clinics and providing treatment for mental health disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The firm is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. The company seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The firm has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.
Read More Braxia Scientific Corp (BRAX.CN) Chart
Key Statistics of Braxia Scientific Corp (BRAX.CN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
CAD0.01Volume
109.05KP/E Ratio (TTM)
-52 Week Range
Market Cap
1.32MAvg. Volume
115.34KDividend Yield
-Financial Metrics & Statements of Braxia Scientific Corp (BRAX.CN)
FAQ's for Braxia Scientific Corp (BRAX.CN)
- According to Musaffa’s Shariah screening methodology, Braxia Scientific Corp (BRAX.CN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.